Near-patient Molecular Solutions Market Outlook (2023 to 2033)
The near-patient molecular solutions market is estimated to register a magnificent CAGR of 8% during the forecast period. According to FMI, the market is projected to be valued at US$ 7.56 Billion by 2033, up from US$ 3.5 Billion
Smart apps, wearable gear, and biosensors are some of the emerging technologies in the healthcare business that are simple to connect to patients' general health. These advanced technologies are increasing the demand for near-patient molecular solutions during the forecast period.
Attributes
Details
Near-patient Molecular Solutions Market (2023)
US$ 3.5 Billion
Near-patient Molecular Solutions Market (2033)
US$ 7.56 Billion
Near-patient Molecular Solutions Market CAGR (2023 to 2033)
8%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Advanced Healthcare Devices Driving the Near-patients Molecular Solutions Market Growth
The driving concept of testing closer to get appropriate and quick results about the health condition increases the demand for near-patient molecular solutions.
The increasing prevalence of diseases such as diabetes and cardiac diseases is increasing the adoption of near-patient molecular solutions for effective treatment during the forecast period.
Moreover, manufacturers are developing easy-to-use home-based point-of-care devices accelerating demand for near-patient molecular solutions.
The growing laboratory test for different healthcare devices and techniques are increasing the demand for near-patient molecular solutions during the forecast period.
The rising number of elderly patients and multi-chronic conditions are driving the market expansion during the foreseen time.
Healthcare manufacturing companies are pushing the envelope to provide better point-of-care devices that are more reliable, fast, and easier to process.
The market is growing at a moderate pace by occupying a majestic CAGR. Apart from its expansion, the market has a few limiting factors as follows
The shortage of highly skilled staff in the healthcare sector hampers market growth during the forecast period.
Lack of knowledge and unavailability of advanced devices declined the market growth during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Global Near-patient Molecular Solutions Market Historical Analysis and Forecast Outlook
The growing end-use sectors such as hospitals, home care, diagnostic laboratories, and research laboratories increase the market expansion during the forecast period. However, the market for near-patient molecular solutions increased from US$ 3.03 Billion between 2018 and 2022 with an impressive CAGR of 7.5%.
The rising improvement in healthcare devices and Smart applications with AI technology increases the adoption of near-patient molecular solutions. The key companies are paying attention to advancing the values of the near-patient molecular solutions market to provide effective treatment.
Short Term (2022 to 2025): The healthcare industry is growing by adopting Smart devices, IoT, and robotic systems expected to boost market expansion.
Medium Term (2025 to 2028): Growing rapid urbanization, data monetization, and increasing R&D activities are likely to drive the market.
Long Term (2028 to 2032): The top healthcare sector stimulates cloud computing technology and real-time data to exchange information leading to market expansion during the forecast period.
The global near-patient molecular solutions market is anticipated to be valued at US$ 7.56 Billion by 2032 with a CAGR of 8%.
Comparative View of Adjacent Global Near-patient Molecular Solutions Market
Near-patient Molecular Solutions Market:
Differentiating Aspects
Near-patient Molecular Solutions Market
CAGR
8%
Market Valuation in 2023
US$ 3.5 Billion
Projected Market Value in 2033
US$ 7.56 Billion
Driver
The increasing prevalence of diseases such as diabetes and cardiac diseases is increasing the adoption of near-patient molecular solutions for effective treatment during the forecast period.
Opportunity
The growing laboratory test for different healthcare devices and techniques are increasing the demand for near-patient molecular solutions during the forecast period. Moreover, manufacturers are developing easy-to-use home-based point-of-care devices accelerating demand for near-patient molecular solutions.
Key Trend
The growing technologies in the healthcare sector, such as smart apps, wearable devices, and biosensors are easy to link to patients' overall health. These advanced technologies are increasing the demand for near-patient molecular solutions during the forecast period.
IoT Services and Solutions Market:
Differentiating Aspects
IoT Services and Solutions Market
CAGR
15.5%
Market Valuation in 2023
US$ 268.64 Billion
Projected Market Value in 2033
US$ 1,134,99 Billion
Driver
The growing technology development, real-time access, and improved network connection are increasing the demand for IoT solutions and services during the forecast period.
Opportunity
The innovation of 5-speed internet connectivity, increase efficiency, and growing IoT devices are growing the IoT solutions and services market size during the forecast period.
Key Trend
Innovation of wireless networks, rising demand for technologies, cloud-based systems, and improved and fast workflow are increasing the IoT solutions and services market trends.
Molecular Microbiology Market:
Differentiating Aspects
Molecular Microbiology Market
CAGR
10%
Market Valuation in 2023
US$ 6.73 Billion
Projected Market Value in 2033
US$ 17.46 Billion
Driver
The rising prevalence of infectious diseases, genetic syndromes, tuberculosis, and the rapid expansion of the healthcare industry are some of the major factors driving the global molecular microbiology market.
Opportunity
Changing methodologies for the early and rapid diagnosis of diseases coupled with rising awareness about infectious diseases and their impact disastrous health impacts are expected to further bolster the growth of the molecular microbiology market.
Key Trend
Growth in the market is driven by an increasing patient pool, rising diagnostic rates, the presence of leading market players, the growing popularity of molecular diagnostics methods, and the easy availability of user-friendly testing solutions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which Segment to Remain Dominant in the Technology Category?
By technology, the market is segmented into PCR (Polymerase Chain Reaction) based, Genetic sequencing-based, hybridization-based and microarray-based. The PCR-based segment dominates the global market by contributing a significant role during the forecast period.
The rising adoption of polymerase chain reaction technology to treat a patient is anticipated to boost the market expansion during the forecast period. The increase in the innovation of molecular diagnostic devices is likely to rise the demand for polymerase chain reaction technology.
Which is the Most Favored Product Type Category in the Near-patient Molecular Solutions Market?
By product type, the market is classified into cardiometabolic monitoring kits, infectious diseases testing kits, coagulation monitoring kits, pregnancy and fertility, and hematology testing kits. Infectious disease testing kits dominate the global market by capturing a relevant share during the forecast period. The growing prevalence of diseases such as SARS COV-19 is likely to increase the demand for infectious disease testing kits during the forecast period.
Which End-use Category Prefer to Dominates the Global Market?
By end-use segment, the hospital's category dominates the market by occupying the highest share during the forecast period. Due to the rising number of patients treating their infectious diseases such as chronic, diabetes, and other diagnostic treatment during the forecast period. In addition, homecare, research laboratories, and diagnostic laboratories are other remaining categories that contribute a significant role in the market growth.
Country-wise Insights
Rising Well-established Healthcare Sector Uplift the USA Near-patient Molecular Solutions Market
North America dominates the global market by securing a significant share during the forecast period. The USA is leading the global market with a rising number of clinical studies and good reimbursement policies for diagnostic procedures during the forecast period. In addition the growing demand for near-patient testing devices and the presence of prominent players increasing the market expansion during the forecast period.
The growing government support and investment among key companies are accelerating the demand for near-patient molecular solutions during the forecast period. However, the USA anticipated uplifting the market size with its new technologies and advanced healthcare infrastructure in the coming years.
A glimpse of the United Kingdom Near-patient Molecular Solutions Market
The United Kingdom is anticipated to secure a significant share of the global market during the forecast period. The United Kingdom market has recently benefited from the increased availability of cutting-edge central laboratories for testing and well-known manufacturers.
The growing advanced automatic molecular testing device and research operation in the United Kingdom are increasing the market opportunities during the forecast period. In addition, rising well-equipped hospitals and a rising generic population are expected to drive the market share in recent years.
An Eagle Eye on the Asia Pacific Near-patient Molecular Solutions Market
The Asia Pacific Region is advancing global marketing by capturing a significant share during the forecast period. The Asia Pacific is the fastest-growing region that rapidly expanding its market size in recent years. The rising disposable income and rapid urbanization are accelerating the demand for near-patient molecular solutions during the forecast period.
Asian-countries
Korea
Driving Factors
The Korean nation is contributing a prominent role in the upsurge of the market size due to an increase the infectious diseases, a large patient population, and advanced healthcare equipment. The growing key healthcare manufacturers and development in the healthcare sector are surging the Korean near-patient molecular solutions market opportunities during the forecast period.
Asian-countries
Japan
Driving Factors
Japan is another nation in the region that contribute a prominent role in the global market during the forecast period. Rising rapid flue testing devices and innovations in the healthcare industry are accelerating the demand for near-patient molecular solutions during the forecast period.
Start-up Ecosystem
How are Start-up Companies Experimenting in the Near-patients Molecular Solutions Market?
Company Name
Sherlock Biosciences
Founded Year
2019
Description
Sherlock Biosciences is a near-patient molecular solution USA-based start-up company founded in 2019. The start-up provides synthetic biology and improves the patient's health from the diagnostic. The company aims to provide better diagnostics treatment to the patient with faster, more effective, and affordable tests. They are advancing molecular testing devices to offer better diagnostic solutions.
Company Name
Nucleai
Founded Year
2017
Description
Nucleai is an Israel-based start-up company that provides AI-powered healthcare applications to clinicians and pharmaceutical companies. The start-up enhances the support of treatment and drug development with biomarker discovery technology. They are developing a better understanding of cancer biology, improving patient healthcare, and optimizing with real-world pathology and molecular datasets. The company is a campaign across the nation to raise awareness among patients and improve patients' health with the best diagnostic tools.
Company Name
Yemaachi Biotechnology
Founded Year
2020
Description
Yemaachi Biotechnology is an Africa-based Cancer research start-up company that redefined cancer-diagnosed treatment with their innovative and suitable biomedical research. The start-up provides advanced medical treatment across the nation with its research and development activities. The company partnered with the biotechnology and pharmaceutical industries to develop advanced therapeutics and molecular diagnostics with novel technology. The company also provides clinical services such as molecular cancer test services with prognostic testing and NGS-based screening.
Competitive Landscape
The market is consolidated by the number of prominent vendors in the region during the forecast period. Prominent vendors play a crucial role in the healthcare field to uplift the market size during the forecast period. These players are focusing on fulfilling the consumer's requirements as per their demand in recent years.
The prominent vendors are making several marketing strategies to acquire a lion’s share of the market. Innovating the relevant products through their research and development activities increases the market opportunities during the forecast period. Some of the marketing tactics adopted by these players include collaborations, partnerships, mergers, acquisitions, agreements, and product launches.
Recent Developments in the Driving Training Simulator Market
In Jan 2021, MatMaCorp- a molecular diagnostic systems developer, was granted a (EUA) Emergency Use Authorization from US FDA for the 2SF RNA test for the COVID-19 virus. The detection of COVID-19 among patients by their portable detection systems.
In Feb 2021, Bio-Rad laboratory received a (EUA) Emergency Use Authorization from the US FDA for COVID-19 flu. The company takes in-charge to detects COVID Waves in a single multiplex reaction.
In Jun 2021, Bio-Rad Laboratories announced a partnership agreement with Seegene Company for multiplex molecular diagnostics treatment, clinical development, and products related to molecular diagnostics.
Segmentation by Category in Market for Near-patients Molecular Solutions
By Technology:
PCR-based
Genetic sequencing based
Hybridization-based
Microarray-based
By Product Type:
Infectious diseases testing kits
Cardiometabolic monitoring kits
Pregnancy and fertility
Coagulation monitoring kits
Hematology testing kits
Urinalysis testing kits
Glucose monitoring kits
Drugs-of-abuse testing kits
Testing kits
Fecal occult testing kits
Tumor/cancer markers
Cholesterol test strips
Other products
By End User:
Hospitals
Homecare
Diagnostic Laboratories
Research Laboratories
By Region:
North America
Latin America
Europe
Asia Pacific
Middle East and Africa(MEA)
Frequently Asked Questions
How Much is the Near-patients Molecular Solutions Market Currently Worth?
The near-patient molecular solutions market is valued at US$ 3.5 Million.
Why Near-patients Molecular Solutions Market has High Growth Potential?
The near-patients molecular solutions market is likely to register a CAGR of 8% during the forecast period.
Where will Manufacturers find the Most Opportunities in the Near-patients Molecular Solutions Industry?
North America holds the most opportunities in the near-patient molecular solutions market.
Table of Content
1. Executive Summary | Near-Patient Molecular Solutions Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2022 to 2032
5.3.1. PCR-based
5.3.2. Genetic Sequencing Based
5.3.3. Hybridization-based
5.3.4. Microarray-based
5.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Technology, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
6.3.1. Infectious Diseases Testing Kits
6.3.2. Cardio-Metabolic Monitoring Kits
6.3.3. Pregnancy and Fertility
6.3.4. Coagulation Monitoring Kits
6.3.5. Hematology Testing Kits
6.3.6. Urinalysis Testing Kits
6.3.7. Glucose Monitoring Kits
6.3.8. Drugs-of-abuse Testing Kits
6.3.9. Testing Kits
6.3.10. Fecal Occult Testing Kits
6.3.11. Tumor/Cancer Markers
6.3.12. Cholesterol Test Strips
6.3.13. Other Products
6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
7.3.1. Hospitals
7.3.2. Homecare
7.3.3. Diagnostic Laboratories
7.3.4. Research Laboratories
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa(MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Technology
9.2.3. By Product Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Technology
9.3.3. By Product Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Technology
10.2.3. By Product Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Technology
10.3.3. By Product Type
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Technology
11.2.3. By Product Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Product Type
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Technology
12.2.3. By Product Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Product Type
12.3.4. By End User
12.4. Key Takeaways
13. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa(MEA)
13.2.2. By Technology
13.2.3. By Product Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technology
13.3.3. By Product Type
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Technology
14.1.2.2. By Product Type
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Technology
14.2.2.2. By Product Type
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Technology
14.3.2.2. By Product Type
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Technology
14.4.2.2. By Product Type
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Technology
14.5.2.2. By Product Type
14.5.2.3. By End User
14.6. United Kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Technology
14.6.2.2. By Product Type
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Technology
14.7.2.2. By Product Type
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Technology
14.8.2.2. By Product Type
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Technology
14.9.2.2. By Product Type
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Technology
14.10.2.2. By Product Type
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Technology
14.11.2.2. By Product Type
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Technology
14.12.2.2. By Product Type
14.12.2.3. By End User
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Technology
14.13.2.2. By Product Type
14.13.2.3. By End User
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Technology
14.14.2.2. By Product Type
14.14.2.3. By End User
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Technology
14.15.2.2. By Product Type
14.15.2.3. By End User
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Technology
14.16.2.2. By Product Type
14.16.2.3. By End User
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Technology
14.17.2.2. By Product Type
14.17.2.3. By End User
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Technology
14.18.2.2. By Product Type
14.18.2.3. By End User
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Technology
14.19.2.2. By Product Type
14.19.2.3. By End User
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Technology
14.20.2.2. By Product Type
14.20.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Technology
15.3.3. By Product Type
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Abbott Laboratories, Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Roche Diagnostics Limited
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Siemens AG
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Beckman Coulter, Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Becton, Dickinson, and Company
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Johnson & Johnson
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. PTS Diagnostics
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Nova Biomedical
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Bayer Healthcare
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. BioMerieux
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Technology, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2032
Table 4: Global Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by Technology, 2017 to 2032
Table 7: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032
Table 8: North America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 10: Latin America Market Value (US$ Million) Forecast by Technology, 2017 to 2032
Table 11: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2032
Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: Europe Market Value (US$ Million) Forecast by Technology, 2017 to 2032
Table 15: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2032
Table 16: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 18: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2017 to 2032
Table 19: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2017 to 2032
Table 20: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 21: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 22: MEA Market Value (US$ Million) Forecast by Technology, 2017 to 2032
Table 23: MEA Market Value (US$ Million) Forecast by Product Type, 2017 to 2032
Table 24: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Technology, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by End User, 2022 to 2032
Figure 4: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 8: Global Market Value (US$ Million) Analysis by Technology, 2017 to 2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 11: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 14: Global Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 17: Global Market Attractiveness by Technology, 2022 to 2032
Figure 18: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 19: Global Market Attractiveness by End User, 2022 to 2032
Figure 20: Global Market Attractiveness by Region, 2022 to 2032
Figure 21: North America Market Value (US$ Million) by Technology, 2022 to 2032
Figure 22: North America Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 23: North America Market Value (US$ Million) by End User, 2022 to 2032
Figure 24: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 28: North America Market Value (US$ Million) Analysis by Technology, 2017 to 2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 31: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 34: North America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 37: North America Market Attractiveness by Technology, 2022 to 2032
Figure 38: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 39: North America Market Attractiveness by End User, 2022 to 2032
Figure 40: North America Market Attractiveness by Country, 2022 to 2032
Figure 41: Latin America Market Value (US$ Million) by Technology, 2022 to 2032
Figure 42: Latin America Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 43: Latin America Market Value (US$ Million) by End User, 2022 to 2032
Figure 44: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 48: Latin America Market Value (US$ Million) Analysis by Technology, 2017 to 2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 51: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 57: Latin America Market Attractiveness by Technology, 2022 to 2032
Figure 58: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 59: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 61: Europe Market Value (US$ Million) by Technology, 2022 to 2032
Figure 62: Europe Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 63: Europe Market Value (US$ Million) by End User, 2022 to 2032
Figure 64: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 68: Europe Market Value (US$ Million) Analysis by Technology, 2017 to 2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 71: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 74: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 77: Europe Market Attractiveness by Technology, 2022 to 2032
Figure 78: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 79: Europe Market Attractiveness by End User, 2022 to 2032
Figure 80: Europe Market Attractiveness by Country, 2022 to 2032
Figure 81: Asia Pacific Market Value (US$ Million) by Technology, 2022 to 2032
Figure 82: Asia Pacific Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 83: Asia Pacific Market Value (US$ Million) by End User, 2022 to 2032
Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2017 to 2032
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2017 to 2032
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 97: Asia Pacific Market Attractiveness by Technology, 2022 to 2032
Figure 98: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 99: Asia Pacific Market Attractiveness by End User, 2022 to 2032
Figure 100: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 101: MEA Market Value (US$ Million) by Technology, 2022 to 2032
Figure 102: MEA Market Value (US$ Million) by Product Type, 2022 to 2032
Figure 103: MEA Market Value (US$ Million) by End User, 2022 to 2032
Figure 104: MEA Market Value (US$ Million) by Country, 2022 to 2032
Figure 105: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 108: MEA Market Value (US$ Million) Analysis by Technology, 2017 to 2032
Figure 109: MEA Market Value Share (%) and BPS Analysis by Technology, 2022 to 2032
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Technology, 2022 to 2032
Figure 111: MEA Market Value (US$ Million) Analysis by Product Type, 2017 to 2032
Figure 112: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 114: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 115: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 116: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 117: MEA Market Attractiveness by Technology, 2022 to 2032
Figure 118: MEA Market Attractiveness by Product Type, 2022 to 2032
Figure 119: MEA Market Attractiveness by End User, 2022 to 2032
Figure 120: MEA Market Attractiveness by Country, 2022 to 2032
